Cargando…

Targeting WASF3 Signaling in Metastatic Cancer

Increasing evidence indicates that cancer metastasis is regulated by specific genetic pathways independent of those controlling tumorigenesis and cancer growth. WASF3, a Wiskott–Aldrich syndrome protein family member, appears to play a major role not only in the regulation of actin cytoskeleton dyna...

Descripción completa

Detalles Bibliográficos
Autores principales: Loveless, Reid, Teng, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830529/
https://www.ncbi.nlm.nih.gov/pubmed/33467681
http://dx.doi.org/10.3390/ijms22020836
_version_ 1783641436539846656
author Loveless, Reid
Teng, Yong
author_facet Loveless, Reid
Teng, Yong
author_sort Loveless, Reid
collection PubMed
description Increasing evidence indicates that cancer metastasis is regulated by specific genetic pathways independent of those controlling tumorigenesis and cancer growth. WASF3, a Wiskott–Aldrich syndrome protein family member, appears to play a major role not only in the regulation of actin cytoskeleton dynamics but also in cancer cell invasion/metastasis. Recent studies have highlighted that WASF3 is a master regulator and acts as a pivotal scaffolding protein, bringing the various components of metastatic signaling complexes together both spatially and temporally. Herein, targeting WASF3 at the levels of transcription, protein stability, and phosphorylation holds great promise for metastasis suppression, regardless of the diverse genetic backgrounds associated with tumor development. This review focuses on the critical and distinct contributions of WASF3 in the regulation of signal pathways promoting cancer cell invasion and metastasis.
format Online
Article
Text
id pubmed-7830529
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78305292021-01-26 Targeting WASF3 Signaling in Metastatic Cancer Loveless, Reid Teng, Yong Int J Mol Sci Review Increasing evidence indicates that cancer metastasis is regulated by specific genetic pathways independent of those controlling tumorigenesis and cancer growth. WASF3, a Wiskott–Aldrich syndrome protein family member, appears to play a major role not only in the regulation of actin cytoskeleton dynamics but also in cancer cell invasion/metastasis. Recent studies have highlighted that WASF3 is a master regulator and acts as a pivotal scaffolding protein, bringing the various components of metastatic signaling complexes together both spatially and temporally. Herein, targeting WASF3 at the levels of transcription, protein stability, and phosphorylation holds great promise for metastasis suppression, regardless of the diverse genetic backgrounds associated with tumor development. This review focuses on the critical and distinct contributions of WASF3 in the regulation of signal pathways promoting cancer cell invasion and metastasis. MDPI 2021-01-15 /pmc/articles/PMC7830529/ /pubmed/33467681 http://dx.doi.org/10.3390/ijms22020836 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Loveless, Reid
Teng, Yong
Targeting WASF3 Signaling in Metastatic Cancer
title Targeting WASF3 Signaling in Metastatic Cancer
title_full Targeting WASF3 Signaling in Metastatic Cancer
title_fullStr Targeting WASF3 Signaling in Metastatic Cancer
title_full_unstemmed Targeting WASF3 Signaling in Metastatic Cancer
title_short Targeting WASF3 Signaling in Metastatic Cancer
title_sort targeting wasf3 signaling in metastatic cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830529/
https://www.ncbi.nlm.nih.gov/pubmed/33467681
http://dx.doi.org/10.3390/ijms22020836
work_keys_str_mv AT lovelessreid targetingwasf3signalinginmetastaticcancer
AT tengyong targetingwasf3signalinginmetastaticcancer